|Articles|October 31, 2022
Medable Adds New Oncology Offering
Advertisement
Medable announced a new oncology offering. It is an end-to-end suite that includes DCT applications such as Total Consent and Televisit, an eCOA oncology library, and protocol design consulting—with a single point of entry for patients, sites, and sponsors.
Read more about the new offering
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
A Shot in the Arm to Traditional Vaccine Trial Strategy
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5